Supreme Court to Address Mootness Doctrine in Class Action Litigation

November 15, 2012

This article was co-authored by Rhonda Coleman, a law clerk at Wexler Wallace. Rhonda is a third year law student at Loyola University Chicago School of Law. This term, the Supreme Court of the United States is likely to resolve[...]

Be Careful What You Ask For

November 12, 2012

In In re Abbott Labs., Inc, 2012 U.S. App. LEXIS 21387 (7th Cir. Oct. 16, 2012), the Seventh Circuit recently held that, by moving to consolidate numerous state court product liability cases under Illinois Supreme Court Rule 384, the plaintiff[...]

Supreme Court to Take Yet Another Look at Arbitration

November 09, 2012

Consumer rights are on the line as the Supreme Court decides to take up mandatory binding arbitration clauses once again.  Last time, in 2011’s AT&T Mobility v. Concepcion decision, the Supreme Court held that corporations can effectively ban class actions—both[...]

Hall of Shame: PayPal’s New User Agreement

November 01, 2012

Changes have come to PayPal’s user agreement, and of course, the changes are not for the benefit PayPal’s customers. The company recently added a section to its user agreement which takes away a user’s right to sue in court. PayPal[...]

In re DDAVP Indirect Purchaser Opinion: Getting It Right

October 29, 2012

Recently, Judge Seibel of the Southern District of New York denied Defendants’ motion to dismiss in the In re DDAVP Indirect Purchaser Antitrust Litigation.[1]  The case involves the drug DDAVP, an antidiuretic containing desmopressin acetate.  Plaintiffs allege that Defendants Ferring[...]

Medical Devices in the Market: Are they Safe, or Just Similarly Dangerous?

October 23, 2012

Efficiency and speed is valued when bringing new medical devices to the market, but what remains relatively unknown are the risks inherent in the current U.S. Food and Drug Administration (FDA) approval process.  The 510(k) process, outlined in the Federal[...]